AI Article Synopsis
- The case describes a rare instance of complete hydatidiform mole with two living fetuses, confirmed through advanced medical techniques.
- The patient had normal fetal karyotype and high β-human chorionic gonadotropin levels, but complications arose, leading to pregnancy termination at 13 weeks due to maternal health issues.
- Patients with this condition should be informed about significant risks like persistent trophoblastic disease, but current clinical management guidelines are limited due to a lack of published cases.
Article Abstract
We describe a rare case of complete hydatidiform mole with twin live fetus (CHMTF) confirmed by histopathology, flow cytometry, and polymerase chain reaction techniques. No malformations were observed, fetal karyotype was normal and β-human chorionic gonadotropin levels were increased (>100,000 IU/ml). Once the patient had been informed of the risks, it was decided to continue the pregnancy, but termination of pregnancy was necessary at week 13 + 5 due to maternal complications consisting of hyperthyroidism, hypertension and vaginal bleeding, followed by persistent trophoblastic disease (PTD). Patients diagnosed with CHMTF should be informed of all known risks, including the considerable risk of PTD, which is similar to - or according to some reports - even higher than that associated with a singleton complete mole and is not increased by continuing pregnancy. Due to the low number of series published, evidence-based clinical management guidelines are lacking.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000338926 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!